- Home
- OUST vs RARE Comparison
OUST vs RARE Comparison
Compare OUST & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUST | RARE |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | 320 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | OUST | RARE |
|---|---|---|
| Price | $62.60 | $33.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 20 |
| Target Price | $39.25 | ★ $59.10 |
| AVG Volume (30 Days) | ★ 4.7M | 2.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $673,000,000.00 |
| Revenue This Year | $33.20 | $13.12 |
| Revenue Next Year | $37.27 | $37.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.13 |
| 52 Week Low | $16.40 | $18.29 |
| 52 Week High | $54.49 | $39.98 |
Technical Indicators
Market Signals| Indicator | OUST | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 72.35 | 80.24 |
| Support Level | $20.71 | $32.64 |
| Resistance Level | N/A | $34.01 |
| Average True Range (ATR) | 5.91 | 1.53 |
| MACD | 1.05 | 0.78 |
| Stochastic Oscillator | 94.52 | 86.32 |
Price Performance
Historical ComparisonAbout OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.